• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导性急性肝损伤:一例报告。

-induced acute liver injury: A case report.

作者信息

Tóth Marcell, Benedek Andrea E, Longerich Thomas, Seitz Helmut-Karl

机构信息

Institute of Pathology University Hospital Heidelberg Heidelberg Germany.

Department of Medicine Salem Medical Center Heidelberg Germany.

出版信息

Clin Case Rep. 2023 Mar 14;11(3):e7078. doi: 10.1002/ccr3.7078. eCollection 2023 Mar.

DOI:10.1002/ccr3.7078
PMID:36937644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10014511/
Abstract

Drug-induced liver injury became one of the most important liver disorders and diagnostic challenge for clinicians and pathologists. Here, we report a rare case of -induced acute liver injury. The patient developed jaundice 2 weeks after starting intake and recovered within 5 months after withdrawal without any specific treatment.

摘要

药物性肝损伤已成为临床医生和病理学家面临的最重要的肝脏疾病之一及诊断挑战。在此,我们报告一例罕见的由……引起的急性肝损伤病例。该患者在开始摄入……2周后出现黄疸,并在停药后5个月内未接受任何特殊治疗而康复。

相似文献

1
-induced acute liver injury: A case report.诱导性急性肝损伤:一例报告。
Clin Case Rep. 2023 Mar 14;11(3):e7078. doi: 10.1002/ccr3.7078. eCollection 2023 Mar.
2
Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.印度人参引起的肝损伤:来自冰岛和美国药物性肝损伤网络的病例系列
Liver Int. 2020 Apr;40(4):825-829. doi: 10.1111/liv.14393. Epub 2020 Feb 11.
3
Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury.草药产品的肝脏危害:一例 Ashwagandha 引起的肝损伤病例报告。
Int J Environ Res Public Health. 2023 Feb 22;20(5):3921. doi: 10.3390/ijerph20053921.
4
Drug-induced hepatocellular injury due to herbal supplement ashwagandha.草药补充剂南非醉茄导致的药物性肝细胞损伤。
J R Coll Physicians Edinb. 2021 Dec;51(4):363-365. doi: 10.4997/JRCPE.2021.409.
5
Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause.经更新的RUCAM评估的阿育吠陀印度人参引起的草药性肝损伤:一个新出现的病因
Pharmaceuticals (Basel). 2023 Aug 10;16(8):1129. doi: 10.3390/ph16081129.
6
Ashwagandha-induced liver injury-A case series from India and literature review.印度的一项病例系列及文献复习:印度麻导致的肝损伤。
Hepatol Commun. 2023 Sep 27;7(10). doi: 10.1097/HC9.0000000000000270. eCollection 2023 Oct 1.
7
DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of (Ashwagandha).作为(印度人参)草药产品所观察到的肝脏毒性的潜在原因,睡茄内酯对DNA的损伤。
Curr Res Toxicol. 2021 Feb 16;2:72-81. doi: 10.1016/j.crtox.2021.02.002. eCollection 2021.
8
Supplements Are Not a Synonym for Safe: Suspected Liver Injury From Ashwagandha.补充剂并非安全的代名词:印度人参引发的疑似肝损伤
Fed Pract. 2023 Sep;40(9):315-319. doi: 10.12788/fp.0409. Epub 2023 Sep 12.
9
Acute Liver Injury After Long-Term Herbal "Liver Cleansing" and "Sleep Aid" Supplement Use.长期服用草药“肝脏排毒”和“助眠”补充剂后导致的急性肝损伤。
J Emerg Med. 2021 May;60(5):610-614. doi: 10.1016/j.jemermed.2021.01.004. Epub 2021 Feb 10.
10
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.印度阿育吠陀药用植物用于治疗神经退行性疾病的科学依据:南非醉茄。
Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238.

引用本文的文献

1
Etiopathogenic and Therapeutic Considerations in a Multiple Sclerosis Case with Acute Toxic Hepatitis.一例伴有急性中毒性肝炎的多发性硬化症病例的病因及治疗考量
Reports (MDPI). 2025 Mar 26;8(2):38. doi: 10.3390/reports8020038.
2
Unmasking Potential Withdrawal Effects of Ashwagandha: A Case Report and Review.揭示印度人参潜在的戒断效应:一例病例报告及文献综述
Cureus. 2025 May 6;17(5):e83577. doi: 10.7759/cureus.83577. eCollection 2025 May.
3
Liver toxicity and repair evaluated by histopathology and electric modulus.通过组织病理学和电模量评估肝脏毒性和修复情况。

本文引用的文献

1
A Case of Supplement-Induced Hepatitis.一例补充剂诱发的肝炎病例。
Cureus. 2022 Oct 18;14(10):e30433. doi: 10.7759/cureus.30433. eCollection 2022 Oct.
2
Comprehensive review of hepatotoxicity associated with traditional Indian Ayurvedic herbs.与印度传统阿育吠陀草药相关的肝毒性综合综述。
World J Hepatol. 2020 Sep 27;12(9):574-595. doi: 10.4254/wjh.v12.i9.574.
3
Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.印度人参引起的肝损伤:来自冰岛和美国药物性肝损伤网络的病例系列
Toxicol Res (Camb). 2024 Oct 15;13(5):tfae175. doi: 10.1093/toxres/tfae175. eCollection 2024 Oct.
4
Role of liver biopsy in the management of idiosyncratic DILI.肝活检在特异质性药物性肝损伤管理中的作用。
Liver Int. 2025 Mar;45(3):e16097. doi: 10.1111/liv.16097. Epub 2024 Sep 10.
5
Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause.经更新的RUCAM评估的阿育吠陀印度人参引起的草药性肝损伤:一个新出现的病因
Pharmaceuticals (Basel). 2023 Aug 10;16(8):1129. doi: 10.3390/ph16081129.
Liver Int. 2020 Apr;40(4):825-829. doi: 10.1111/liv.14393. Epub 2020 Feb 11.
4
Hepatitis caused by herpes viruses: A review.疱疹病毒引起的肝炎:综述。
J Dig Dis. 2018 Aug;19(8):446-455. doi: 10.1111/1751-2980.12640. Epub 2018 Jul 30.
5
Liver injury from herbal and dietary supplements.草药和膳食补充剂导致的肝损伤。
Hepatology. 2017 Jan;65(1):363-373. doi: 10.1002/hep.28813. Epub 2016 Nov 17.
6
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.899例药物性肝损伤患者的特征与转归:药物性肝损伤网络(DILIN)前瞻性研究
Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6.
7
Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.尽管使用了阿昔洛韦治疗,但肝再次移植后仍出现复发性单纯疱疹病毒肝炎。
Liver Transpl. 2005 Oct;11(10):1289-94. doi: 10.1002/lt.20567.
8
Safety of acyclovir: a summary of the first 10 years experience.阿昔洛韦的安全性:首个10年经验总结
J Med Virol. 1993;Suppl 1:67-73. doi: 10.1002/jmv.1890410513.